Bone Loss in Lymphoma Patients Receiving Frontline Therapy: Urine NTx and Bone Specific Alkaline Phosphatase Provide Early Evidence of Zoledronic Acid Response.
Abstract. Abstract 3922Poster Board III-858Abstract:Patients diagnosed with lymphoma are at high risk of developing osteoporosis. We have shown previously that